EUCTR2010-019398-14-NL进行中（未招募）不适用
IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATIO
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adult patients (18 years or older) who have received an ABO-compatible single-organ kidney transplant from a living donor and who participated in study METC-2010-080 will be eligible for entry into the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients need to be on immunosuppressive therapy with tacrolimus and mycophenolate mofetil at 3 months after transplantation.
研究者
相似试验
招募中
4 期
IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATIORenal insufficiencyNL-OMON36311Erasmus MC, Universitair Medisch Centrum Rotterdam194
尚未招募
不适用
IMPROVEMENT OF RENAL FUNCTION BY CONVERSION OF TACROLIMUS TO EVEROLIMUS 3 MONTHS AFTER KIDNEY TRANSPLANTATION.Kidney transplant recipientsTacrolimusEverolimusNiertransplantatie patiëntenNL-OMON24603Erasmus Medical Center250
已完成
不适用
Renal functional improvement after transcatheter aortic valve implantation in patients with chronic kidney diseasesevere aortic valve stenosis chronic kidney diseaseJPRN-UMIN000038576Tokyo Women's Medical University121
招募中
不适用
Evaluation of renal function before and after catheter ablation of atrial fibrillatioatrial fibrillationJPRN-UMIN000027201Gunma Prefectural Cardiovascular Center300
招募中
不适用
Consideration the changes of renal function for renal cell carcinoma patients, administered the molecular target drugs: axitinib, sunitinib and sorafenibRenal cell carcinomaJPRN-UMIN000019393Dokkyo Medical University, Department of Urology30